RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Merck Serono Sa
Merck Serono Sa_20100128
  

Merck Serono Sa patents

Recent patent applications related to Merck Serono Sa. Merck Serono Sa is listed as an Agent/Assignee. Note: Merck Serono Sa may have other listings under different names/spellings. We're not affiliated with Merck Serono Sa, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Merck Serono Sa-related inventors




Date Merck Serono Sa patents (updated weekly) - BOOKMARK this page
01/22/15Puro-dhfr quadrifunctional marker and its use in protein production
04/17/14Benzothiazole derivatives for the treatment of diabetes
04/17/14Thienyl- and furanyl-isoquinolinones and methods for using them
07/04/13Puro-dhfr quadrifunctional marker and its use in protein production
06/06/13Piperazine derivatives and methods of use
05/02/136-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
05/02/13Oxadiazole diaryl compounds
01/03/13Nucleic acid molecules encoding bank1 splice variants
09/20/12Tricyclic pyrazol amine derivatives
09/20/12Triazolopyridine compounds and their use as ask inhibitors
09/20/12Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/13/12Humanized antibodies against human il-22ra
08/09/12Process for the purification of fc-containing proteins
06/14/12Compositions and methods for treating growth hormone deficiency
03/22/12Pyrazole oxadiazole derivatives as s1p1 agonists
02/09/12Oxadiazole derivatives
01/26/12Oxadiazole derivatives
01/05/12Genetic severity markers in multiple sclerosis
12/29/11Pyrazine derivatives and use as pi3k inhibitors
12/22/11Pyrazine derivatives and use as pi3k inhibitors
12/15/11Oxazole pyridine derivatives useful as s1p1 receptor agonists
11/17/11N-hydroxyamide derivatives and use thereof
10/20/114-morpholino-pyrido[3,2-d]pyrimidines
08/04/11Active variants of the il-18 binding protein and medical uses thereof
06/30/11Medication dispenser
04/21/11Use of genetic markers for identifying the response to interferon treatment in multiple sclerosis patients
04/21/11Vectors and methods for screening cells for high expression of protein of interest (poi)
04/14/11Ox40r binding agents
04/14/11Thiazole derivatives and use thereof
03/24/11Child-resistant medication container
03/24/11Thiazole derivatives and use thereof
02/03/11Sulfonamides
01/20/11Ptph1 inhibitors for the treatment of alzheimer's disease
01/13/11Expression vectors comprising the mcmv ie2 promoter
12/02/10Triazole oxadiazoles derivatives
12/02/10Oxadiazole diaryl compounds
12/02/10Piperazine derivatives and methods of use
12/02/10Pyridyl derivatives and their use as therapeutic agents
11/04/10Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
10/14/10Novel bank1 splice variant
10/07/10Method for purifying an fc-containing protein
09/23/10Peg-interferon-beta formulations
09/23/10Oxadiazole derivatives
08/19/106-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
08/05/10Triazolopyridine compounds and their use as ask inhibitors
07/29/10Use of gp130 activators in diabetic neuropathy
07/22/10Method for generating stable cell lines expressing high levels of a protein of interest
07/01/10Puro-dhfr quadrifunctional marker and its use in protein production
06/03/10Novel ox40r binding agents
06/03/10Quinoxaline compounds and use thereof
05/13/10Process for the preparation of piperazine benzothiazoles
03/11/10Purification of fc-taci fusion proteins using the oilbody technology
01/28/10Process for the purification of fc-containing proteins
01/28/10Process for the purification of fc-containing proteins







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merck Serono Sa in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merck Serono Sa with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';